{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:29:20Z","timestamp":1788114560351,"version":"build-2803163510"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J cachexia sarcopenia muscle"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Accurate toxicity reporting in cancer clinical trials is necessary to promote regulatory decision making. Up to 85% of those with some cancers (e.g., oesophagus, head and neck, and pancreas) experience significant progressive weight loss (WL) throughout treatment. Therefore, it is necessary that investigators accurately grade and report WL. We have identified two dangerous and misleading approaches in the CTCAE specific to WL: (1) severity grades and associated clinical descriptions and (2) lack of pretreatment weight and longitudinal weight changes. This review highlights the critical importance of a more accurate, comprehensive and patient\u2010focused WL assessment in oncology clinical trials and the CTCAE. We offer a path forward for identification and management of this life\u2010threatening phenomenon, whether it is due to cancer or an antitumor treatment. The National Cancer Institute should consider the following five ideas and concrete action items for future CTCAE versions: (1) Weight assessment has important implications for toxicity determination and prognosis in clinical trials and should be consistently integrated into study reports; (2) Adverse event assessment should be patient\u2010focused and supported by clinically relevant definitions of each grade level; (3) the CTCAE grades and associated clinical descriptions for WL should be revised to better reflect the impact of WL on trial endpoints and patient safety; (4) WL should be assessed as a continuous variable to capture duration, severity, and trajectory; and (5) WL should be urgently incorporated into the PRO\u2010CTCAE to define the individual impact.<\/jats:p>","DOI":"10.1002\/jcsm.13754","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:40:52Z","timestamp":1741714852000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Weight Loss in Cancer and the 2017 Common Terminology Criteria for Adverse Events\u2014Dangerous and Misleading"],"prefix":"10.1002","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3631-7563","authenticated-orcid":false,"given":"Aynur","family":"Aktas","sequence":"first","affiliation":[{"name":"Department of Supportive Oncology, Levine Cancer Institute Atrium Health  Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal\u00a0C.","family":"Kadakia","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Levine Cancer Institute Atrium Health  Charlotte North Carolina USA"},{"name":"Department of Medical Oncology, Levine Cancer Institute Atrium Health  Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Waldman","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Levine Cancer Institute Atrium Health  Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Levine Cancer Institute Atrium Health  Charlotte North Carolina USA"},{"name":"Hemby Family Endowed Chair in Supportive Oncology, Levine Cancer Institute Atrium Health  Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"e_1_2_14_2_1","unstructured":"v5 C. US Department of Health and Human Services NIH National Cancer Institute (2017) [updated 19 April 20218\/13\/2019]. Available from:https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.018"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2005.09.006"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.1894"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682999"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw420"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.07.015"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607112440285"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.025221"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(05)80001-3"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00152-2"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.1567"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101195"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/spcare\u20102023\u2010004638"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm324"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000096"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu12103101"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61900-X"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000922"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174368"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0830"},{"key":"e_1_2_14_24_1","unstructured":"National Cancer Institute Division of Cancer Control & Population Sciences.\u201cPatient\u2010Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO\u2010CTCAE\u00ae) \u201d Available from:https:\/\/healthcaredelivery.cancer.gov\/pro\u2010ctcae\/ accessed 1 February 2024."},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05689-2"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcsm.13754","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcsm.13754","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcsm.13754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:13:40Z","timestamp":1771215220000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcsm.13754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1002\/jcsm.13754"],"URL":"https:\/\/doi.org\/10.1002\/jcsm.13754","archive":["Portico"],"relation":{},"ISSN":["2190-5991","2190-6009"],"issn-type":[{"value":"2190-5991","type":"print"},{"value":"2190-6009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"2024-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13754"}}